First-in-human Study of S-588210 (S-488210+S-488211)

Conditions:   Lung Cancer;   Head and Neck Cancer;   Bladder Cancer;   Esophageal Cancer;   Mesothelioma Interventions:   Biological: S-488210;   Biological: S-488211 Sponsor:   Shionogi Recruiting

Source: ClinicalTrials.gov - March 20, 2020 Category: Research Source Type: clinical trials